Pulmonary disease, chronic obstructive Trials in North Dartmouth, United States
Conditions / Pulmonary disease, chronic obstructive / North Dartmouth, United States
Research into Pulmonary disease, chronic obstructive spans multiple therapeutic approaches and trial phases.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01696058 | Co-administration of Olodaterol Respimat® and Tiotropium Handihaler® | COMPLETED | PHASE3 |
| NCT01694771 | Co-administration of Olodaterol Respimat® and Tiotropium Handihaler® | COMPLETED | PHASE3 |
| NCT01662986 | Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2 | COMPLETED | PHASE4 |
| NCT01019694 | Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |
| NCT02296138 | Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease. | COMPLETED | PHASE3 |
| NCT00500318 | A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT02164513 | A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT01431287 | Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT00671073 | Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE2 |
| NCT01313676 | Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease | COMPLETED | PHASE3 |